Nora-Djoher Abrous Inserm Researcher Inserm Unit 1215 Neurocentre Magendie “Neurogenesis and physiopathology” team leader. +33 (0)5 57 57 36 86 email@example.com
Drug addiction behaviors and vulnerability to relapse are linked to our brain’s ability to produce new neurons. This is the finding of Inserm researchers from Neurocentre Magendie at the University of Bordeaux, after observing the behavior of mice taught to self-administer cocaine. Their results, to be published in Molecular Psychiatry, show a link between the deficient production of new neurons in the hippocampus and addiction to drugs.
In the brain, the hippocampus is one of the centers of memory. It includes the dentate gyrus, which has the particularity of producing new neurons (a phenomenon known as neurogenesis) in adults. Abnormal neurogenesis is correlated with a number of neuropsychiatric disorders, such as memory or mood disorders.
Although a link between erratic neurogenesis and drug addiction has already been suspected, there has been no scientific proof to back up this hypothesis until now. The Inserm research teams of Nora Abrous and Pier-Vicenzo Piazza from Neurocentre Magendie (Unit 1215) of the University of Bordeaux, studied the role of neurogenesis in cocaine addiction.
Two groups of mice were compared: one healthy and one genetically engineered to have reduced hippocampal neurogenesis. The mice were trained to self-administer cocaine by introducing their noses into a hole to trigger the intravenous diffusion of cocaine in their bloodstream. The number of actions that they needed to perform to obtain a similar quantity of drug was then gradually increased. The researchers observed that the transgenic mice showed greater motivation (measured in terms of number of actions in the holes) to “work” to obtain cocaine.
The transition to addiction is a process combining repeated exposure to drugs and a vulnerability specific to each individual: by demonstrating that neurogenesis is a key factor in vulnerability to addiction, this research offers new perspectives in understanding individual fragility in the face of drug dependence.
Inserm researchers at I-Stem – the Institute for Stem Cell Therapy and Exploration of Monogenic Diseases – report encouraging results with metformin, a known diabetes drug, for the symptomatic treatment of Steinert myotonic dystrophy. A phase II trial conducted in 40 patients at ...
A research team in psychiatry at CEA-Neurospin, together with the Mondor Institute of Biomedical Research (INSERM) and the Henri-Mondor (AP-HP) university hospitals, has shown that a genetic variant associated with several psychiatric conditions alters a prefrontal-limbic network, which may increase the risk ...
Depleting adult dentate gyrus neurogenesis increases cocaine-3 seeking behavior Véronique Deroche-Gamonet1,2, Jean-Michel Revest1,2, Jean-François Fiancette1,2, Eric Balado1,2, Muriel Koehl2,3, Noëlle Grosjean2,3, Djoher Nora Abrous2,3, Pier-Vincenzo Piazza1,2 1 Neurocentre Magendie, Physiopathology of addiction and traumatic memories group, INSERM U1215, 33077 Bordeaux, France 2 Université de Bordeaux, 33077 Bordeaux, France 3 Neurocentre Magendie, Neurogenesis and physiopathology group, INSERM U1215, 33077 Bordeaux, France Molecular Psychiatry : https://doi.org/10.1038/s41380-018-0038-0